scholarly journals A Cisplatin-Loaded Immunochemotherapeutic Nanohybrid Bearing Immune Checkpoint Inhibitors for Enhanced Cervical Cancer Therapy

2018 ◽  
Vol 57 (13) ◽  
pp. 3426-3430 ◽  
Author(s):  
Na Wang ◽  
Zhigang Wang ◽  
Zoufeng Xu ◽  
Xianfeng Chen ◽  
Guangyu Zhu
Keyword(s):  
Cervical Cancer ◽  
Cancer Therapy ◽  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitors ◽  
Checkpoint Inhibitors

scholarly journals A Cisplatin-Loaded Immunochemotherapeutic Nanohybrid Bearing Immune Checkpoint Inhibitors for Enhanced Cervical Cancer Therapy

2018 ◽  
Vol 130 (13) ◽  
pp. 3484-3488 ◽  
Author(s):  
Na Wang ◽  
Zhigang Wang ◽  
Zoufeng Xu ◽  
Xianfeng Chen ◽  
Guangyu Zhu
Keyword(s):  
Cervical Cancer ◽  
Cancer Therapy ◽  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitors ◽  
Checkpoint Inhibitors

scholarly journals Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data

Cancers ◽  
2021 ◽  
Vol 13 (9) ◽  
pp. 2089
Author(s):  
Simona Duranti ◽  
Antonella Pietragalla ◽  
Gennaro Daniele ◽  
Camilla Nero ◽  
Francesca Ciccarone ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitors ◽  
Checkpoint Inhibitors ◽  
Hpv Infection ◽  
Phase Iii ◽  
Screening Programs ◽  
Cervical Cancers ◽  
Relapsed Disease

Human papillomavirus (HPV) infection is the recognized cause of almost all cervical cancers. Despite the reduction in incidence due to a wide use of screening programs and a specific vaccine, the prognosis of cervical cancer remains poor, especially for late-stage and relapsed disease. Considering the elevated rates of PD-L1 expression in up to 80% of cervical cancers, a strong rationale supports the use of immunotherapy to restore the immune response against tumor. The aim of this review is to analyze the possible role of immune checkpoint inhibitors in cervical cancer treatment, with a particular focus on the rationale and on the results of phase I and II clinical trials. An overview of ongoing phase III studies with possible future areas of development is also provided.

Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era

2020 ◽  
Vol 26 (16) ◽  
pp. 4201-4205 ◽  
Author(s):  
Michele Maio ◽  
Omid Hamid ◽  
James Larkin ◽  
Alessia Covre ◽  
Maresa Altomonte ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitors ◽  
Checkpoint Inhibitors

scholarly journals Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy

2018 ◽  
Vol 9 ◽  
Author(s):  
Yiyi Yan ◽  
Anagha Bangalore Kumar ◽  
Heidi Finnes ◽  
Svetomir N. Markovic ◽  
Sean Park ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitors ◽  
Checkpoint Inhibitors

A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy

2016 ◽  
Vol 26 (5) ◽  
pp. 469-480 ◽  
Author(s):  
Lisa Kottschade ◽  
Adam Brys ◽  
Tobias Peikert ◽  
Mabel Ryder ◽  
Laura Raffals ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitors ◽  
Multidisciplinary Approach ◽  
Checkpoint Inhibitors

Immune-checkpoint inhibitors and metastatic prostate cancer therapy: Learning by making mistakes

2020 ◽  
Vol 88 ◽  
pp. 102057 ◽  
Author(s):  
Mélanie Claps ◽  
Alessia Mennitto ◽  
Valentina Guadalupi ◽  
Pierangela Sepe ◽  
Marco Stellato ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Therapy ◽  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitors ◽  
Metastatic Prostate Cancer ◽  
Checkpoint Inhibitors ◽  
Prostate Cancer Therapy
Sign in / Sign up

Export Citation Format

Share Document